Stanford Investment Group’s Precigen PGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding PGEN
TS
IAM
MVP
Stanford Investment Group's PGEN Position: Q1 2017 in Review
Stanford Investment Group sold out of Precigen (PGEN) in Q1 2017, closing a stake of 202 shares — an estimated $5K sold.
Stanford Investment Group first reported a position in PGEN in Q1 2015 and held it in 8 quarters. The position peaked at $15K in Q2 2015. 154 funds tracked by Wall St. Rank hold PGEN as of Q1 2017.
- Stanford Investment Group reported no remaining Precigen position as of Q1 2017 after selling out during the quarter.
- Stanford Investment Group sold 202 Precigen shares in Q1 2017, an estimated $5K.
- Stanford Investment Group first reported a position in Precigen in Q1 2015 and held it in 8 quarters.
- Stanford Investment Group's Precigen position peaked at $15K in Q2 2015.
- 154 funds tracked by Wall St. Rank held Precigen as of Q1 2017.
Based on Stanford Investment Group's 13F filing for Q1 2017.